We are live on ! Find out more
GMAB icon

Genmab
GMAB

193 hedge funds and large institutions have $1.43B invested in Genmab in 2022 Q3 according to their latest regulatory filings, with 36 funds opening new positions, 79 increasing their positions, 60 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

71% more first-time investments, than exits

New positions opened: 36 | Existing positions closed: 21

32% more repeat investments, than reductions

Existing positions increased: 79 | Existing positions reduced: 60

24% more capital invested

Capital invested by funds: $1.15B → $1.43B (+$276M)

13.43% more ownership

Funds ownership: 54.07% → 67.5% (+13%)

7% more funds holding

Funds holding: 180 → 193 (+13)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

Holders
193
Holders Change
+13
Holders Change %
+7.22%
% of All Funds
3.32%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
36
Increased
79
Reduced
60
Closed
21
Calls
$7.94M
Puts
–
Net Calls
+$7.94M
Net Calls Change
+$3.56M

Top Buyers

Rank Fund Capital Flow
1
AllianceBernstein
AllianceBernstein
Tennessee
+$203M
2
First Trust Advisors
First Trust Advisors
Illinois
+$45.3M
3
1832 Asset Management
1832 Asset Management
Ontario, Canada
+$33.4M
4
CCM
CAAS Capital Management
New York
+$12.3M
5
Goldman Sachs
Goldman Sachs
New York
+$8.03M

Top Sellers

Rank Fund Capital Flow
1
Artisan Partners
Artisan Partners
Wisconsin
-$15M
2
Macquarie Group
Macquarie Group
Australia
-$9.87M
3
BlackRock
BlackRock
New York
-$6.14M
4
CFM
Capricorn Fund Managers
United Kingdom
-$4.8M
5
HJGA
Hardman Johnston Global Advisors
Connecticut
-$3.12M
Name Holding Trade Value Shares
Change 		Change in
Stake
Skandinaviska Enskilda Banken (SEB)
101
Skandinaviska Enskilda Banken (SEB)
Sweden
$508K -$1.89M -53,878 -77%
FTDI
102
First Trust Direct Indexing
Massachusetts
$474K +$136K +3,887 +36%
Rockefeller Capital Management
103
Rockefeller Capital Management
New York
$454K +$31.7K +904 +7%
VPIM
104
Vanguard Personalized Indexing Management
California
$452K +$178K +5,072 +56%
FA
105
FDx Advisors
Illinois
$446K +$97.4K +2,773 +25%
MCM
106
McKinley Capital Management
Alaska
$434K +$475K +13,524 New
PAS
107
Park Avenue Securities
New York
$428K +$77.8K +2,215 +20%
S
108
SignatureFD
Georgia
$423K +$141K +4,007 +44%
EAM
109
Eagle Asset Management
Florida
$414K -$12.8K -365 -3%
Cetera Investment Advisers
110
Cetera Investment Advisers
Illinois
$403K +$440K +12,533 New
EI
111
Ethic Inc
New York
$402K +$99.5K +2,833 +29%
Creative Planning
112
Creative Planning
Kansas
$395K +$432K +12,304 New
EAM
113
Erste Asset Management
Austria
$383K – – –
WA
114
Wealth Alliance
New York
$383K +$146K +4,172 +54%
ATC
115
Argent Trust Co
Tennessee
$380K -$5.48K -156 -1%
CFM
116
Capricorn Fund Managers
United Kingdom
$378K -$4.8M -136,643 -92%
TI
117
Trexquant Investment
Connecticut
$378K +$413K +11,756 New
CCIA
118
Campbell & Co Investment Adviser
Maryland
$371K -$155K -4,416 -28%
KAS
119
Kestra Advisory Services
Texas
$355K +$40.5K +1,152 +12%
YCM
120
Yousif Capital Management
Michigan
$353K +$31.3K +890 +9%
HSA
121
HBK Sorce Advisory
Pennsylvania
$338K +$126K +3,593 +52%
Janney Montgomery Scott
122
Janney Montgomery Scott
Pennsylvania
$335K +$27.2K +775 +8%
GD
123
Grandfield & Dodd
New York
$330K +$359K +10,210 New
YMRC
124
Yorktown Management & Research Company
Virginia
$325K – – –
OMC
125
Old Mission Capital
Illinois
$313K +$342K +9,733 New
3 4
5
6 7

GMAB Hedge Fund Activity: Q3 2022 in Review

193 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Genmab (GMAB) for Q3 2022, worth a combined $1.43B — up 24% from $1.15B a quarter earlier.

Buyers outnumbered sellers: 36 funds opened new GMAB positions and 21 closed out — a net gain of 15 holders — while 79 added to existing stakes and 60 trimmed.

The largest buyer was AllianceBernstein, opening a new position worth an estimated $203M. The largest seller was Artisan Partners, cutting an estimated $15M.

  • 193 institutional investors held Genmab (GMAB) as of Q3 2022, up from 180 in Q2 2022.
  • Funds reported $1.43B of Genmab stock for Q3 2022, up 24% quarter-over-quarter.
  • 36 funds opened new Genmab positions in Q3 2022 and 21 closed out, a net change of +15 holders.
  • The largest Genmab buyer in Q3 2022 was AllianceBernstein, an estimated $203M added.
  • The largest Genmab seller in Q3 2022 was Artisan Partners, an estimated $15M sold.

Based on aggregated 13F filings for Q3 2022.